Characterization of a new model of parkinson's diisease induced by expression of alpha-synuclein in the midbrain.

Informazioni relative al progetto

ID dell’accordo di sovvenzione: QLK6-CT-2001-51860

Data di avvio 1 Agosto 2002

Data di completamento 31 Luglio 2004

Finanziato da

• Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Costo totale € 150 804,00

Contributo UE € 150 804,00

Coordinato da

LUND UNIVERSITY
Sweden

Obiettivo

Temporal biochemical, molecular and behavioural characterization of the new Parkinson model. Study of the potential of GDNF retrovirus as a therapeutic strategy. Analysis of the susceptibility to 6-OH-dopamine of the dopaminergic system in the model.

Campo scientifico

• medical and health sciences › basic medicine › neurology › parkinson

Programma(i)

• FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Argomento(i)

• 1.1.1.-6. - Key action The Ageing Population and Disabilities

Invito a presentare proposte

Data not available

Meccanismo di finanziamento

RGI - Research grants (individual fellowships)

Coordinatore

LUND UNIVERSITY

• Contributo UE: Nessun dato
• Indirizzo: Paradisgatan 2 ; 221 00 LUND ; Svezia
• Costo totale: Nessun dato